A deep learning model to predict dose distributions for breast cancer radiotherapy.

IF 2.9 4区 医学 Q3 ENDOCRINOLOGY & METABOLISM Discover. Oncology Pub Date : 2025-02-12 DOI:10.1007/s12672-025-01942-4
Xiaorong Hou, Weishi Cheng, Jing Shen, Hui Guan, Yimeng Zhang, Lu Bai, Shaobin Wang, Zhikai Liu
{"title":"A deep learning model to predict dose distributions for breast cancer radiotherapy.","authors":"Xiaorong Hou, Weishi Cheng, Jing Shen, Hui Guan, Yimeng Zhang, Lu Bai, Shaobin Wang, Zhikai Liu","doi":"10.1007/s12672-025-01942-4","DOIUrl":null,"url":null,"abstract":"<p><strong>Purpose: </strong>In this work, we propose to develop a 3D U-Net-based deep learning model that accurately predicts the dose distribution for breast cancer radiotherapy.</p><p><strong>Methods: </strong>This study included 176 breast cancer patients, divided into training, validating and testing sets. A deep learning model based on the 3D U-Net architecture was developed to predict dose distribution, which employed a double encoder combination attention (DECA) module, a cross stage partial + Resnet + Attention (CRA) module, a difficulty perception and a critical regions loss. The performance and generalization ability of this model were evaluated by the voxel mean absolute error (MAE), several clinically relevant dosimetric indexes and 3D gamma passing rates.</p><p><strong>Results: </strong>Our model accurately predicted the 3D dose distributions with each dosage level mirroring the clinical reality in shape. The generated dose-volume histogram (DVH) matched with the ground truth curve. The total dose error of our model was below 1.16 Gy, complying with clinical usage standards. When compared to other exceptional models, our model optimally predicted eight out of nine regions, and the prediction errors for the first planning target volume (PTV1) and PTV2 were merely 1.03 Gy and 0.74 Gy. Moreover, the mean 3%/3 mm 3D gamma passing rates for PTV1, PTV2, Heart and Lung L achieved 91.8%, 96.4%, 91.5%, and 93.2%, respectively, surpassing the other models and meeting clinical standards.</p><p><strong>Conclusions: </strong>This study developed a new deep learning model based on 3D U-Net that can accurately predict dose distributions for breast cancer radiotherapy, which can improve the quality and planning efficiency.</p>","PeriodicalId":11148,"journal":{"name":"Discover. Oncology","volume":"16 1","pages":"165"},"PeriodicalIF":2.9000,"publicationDate":"2025-02-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11822156/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Discover. Oncology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1007/s12672-025-01942-4","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"ENDOCRINOLOGY & METABOLISM","Score":null,"Total":0}
引用次数: 0

Abstract

Purpose: In this work, we propose to develop a 3D U-Net-based deep learning model that accurately predicts the dose distribution for breast cancer radiotherapy.

Methods: This study included 176 breast cancer patients, divided into training, validating and testing sets. A deep learning model based on the 3D U-Net architecture was developed to predict dose distribution, which employed a double encoder combination attention (DECA) module, a cross stage partial + Resnet + Attention (CRA) module, a difficulty perception and a critical regions loss. The performance and generalization ability of this model were evaluated by the voxel mean absolute error (MAE), several clinically relevant dosimetric indexes and 3D gamma passing rates.

Results: Our model accurately predicted the 3D dose distributions with each dosage level mirroring the clinical reality in shape. The generated dose-volume histogram (DVH) matched with the ground truth curve. The total dose error of our model was below 1.16 Gy, complying with clinical usage standards. When compared to other exceptional models, our model optimally predicted eight out of nine regions, and the prediction errors for the first planning target volume (PTV1) and PTV2 were merely 1.03 Gy and 0.74 Gy. Moreover, the mean 3%/3 mm 3D gamma passing rates for PTV1, PTV2, Heart and Lung L achieved 91.8%, 96.4%, 91.5%, and 93.2%, respectively, surpassing the other models and meeting clinical standards.

Conclusions: This study developed a new deep learning model based on 3D U-Net that can accurately predict dose distributions for breast cancer radiotherapy, which can improve the quality and planning efficiency.

Abstract Image

Abstract Image

Abstract Image

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
预测乳腺癌放疗剂量分布的深度学习模型。
目的:在这项工作中,我们提出了一个基于3D u - net的深度学习模型,以准确预测乳腺癌放疗的剂量分布。方法:本研究纳入176例乳腺癌患者,分为训练组、验证组和测试组。采用双编码器组合注意(DECA)模块、跨阶段局部+ Resnet +注意(CRA)模块、难度感知和关键区域损失模型,构建了基于3D U-Net架构的剂量分布预测深度学习模型。通过体素平均绝对误差(MAE)、几种临床相关剂量学指标和3D伽马通过率来评价该模型的性能和泛化能力。结果:该模型准确预测了三维剂量分布,各剂量水平在形状上反映了临床实际情况。生成的剂量-体积直方图(DVH)与地面真值曲线匹配。本模型总剂量误差小于1.16 Gy,符合临床使用标准。与其他异常模型相比,我们的模型对9个区域中的8个区域进行了最优预测,对第一个规划目标体积(PTV1)和PTV2的预测误差仅为1.03 Gy和0.74 Gy。PTV1、PTV2、心肺L的平均3%/3 mm 3D伽玛通过率分别达到91.8%、96.4%、91.5%、93.2%,优于其他模型,符合临床标准。结论:本研究建立了一种新的基于3D U-Net的深度学习模型,可以准确预测乳腺癌放疗的剂量分布,提高了放疗的质量和规划效率。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
Discover. Oncology
Discover. Oncology Medicine-Endocrinology, Diabetes and Metabolism
CiteScore
2.40
自引率
9.10%
发文量
122
审稿时长
5 weeks
期刊最新文献
Functional roles and clinical potential of SOX1 in cancer as a biomarker and therapeutic target. Global scientific growth and thematic development of spatial transcriptomics in oncology research. Prognostic impact of c-MYC and EZH2 expression in small cell and non-small cell lung carcinoma: a single-center retrospective study. PHC2 as a novel predictive biomarker and therapeutic target for cisplatin resistance in lung adenocarcinoma. Mapping research trends in immune cell metabolic reprogramming in breast cancer: a parallel dual-database bibliometric study.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1